Beijing Hotgen Biotech Co Ltd Class A 688068
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 29.96
- Day Range
- CNY 29.12–30.11
- 52-Week Range
- CNY 23.67–55.88
- Bid/Ask
- CNY 29.32 / CNY 29.33
- Market Cap
- CNY 2.71 Bil
- Volume/Avg
- 715,692 / 1.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- 13.75
- Price/Sales
- 5.74
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Beijing Hotgen Biotech Co Ltd is engaged in the development and manufacturing of innovative in-vitro diagnostic, point-of-care-testing and biodefense products.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,036
- Website
- http://www.hotgen.com.cn
Comparables
Valuation
|
Metric
|
688068
|
000710
|
688253
|
|---|---|---|---|
Price/Earnings (Normalized) | 13.75 | — | 23.42 |
Price/Book Value | 0.84 | 1.70 | 2.80 |
Price/Sales | 5.74 | 2.90 | 8.92 |
Price/Cash Flow | 14.76 | 30.36 | 13.52 |
Price/Earnings
688068
000710
688253
Financial Strength
|
Metric
|
688068
|
000710
|
688253
|
|---|---|---|---|
Quick Ratio | 2.87 | 1.63 | 10.60 |
Current Ratio | 6.20 | 2.02 | 11.04 |
Interest Coverage | — | — | 1,693.02 |
Quick Ratio
688068
000710
688253
Profitability
|
Metric
|
688068
|
000710
|
688253
|
|---|---|---|---|
Return on Assets (Normalized) | −1.03% | −13.01% | 4.47% |
Return on Equity (Normalized) | −1.10% | −18.59% | 4.81% |
Return on Invested Capital (Normalized) | −1.96% | −15.87% | 4.51% |
Return on Assets
688068
000710
688253
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Nhgcmhyjb | Gpyg | $586.3 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Xxrcblhf | Zmqmglg | $115.1 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Ydfnlsqd | Hzwrky | $108.2 Bil | |
MRNA
| Moderna Inc | Jqxhdylm | Gvrw | $54.0 Bil | |
ARGX
| argenx SE ADR | Tkmsrdp | Ggqld | $22.0 Bil | |
BNTX
| BioNTech SE ADR | Yndxfkfs | Zqdr | $21.8 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Fhkrqpxq | Tslls | $18.9 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Mpdjxqrm | Tzzzqx | $14.6 Bil | |
INCY
| Incyte Corp | Mpxlpgjg | Mzcgyy | $12.9 Bil | |
RPRX
| Royalty Pharma PLC Class A | Fvpxrrkjs | Wwkngvs | $12.3 Bil |